Relationship between age, gender, BMI, comorbidity and AEFI Variables with S-RBD antibody levels post covid-19 vaccination
DOI:
https://doi.org/10.35335/midwifery.v12i2.1589Keywords:
COVID-19 Vaccine, Covid-19, S-RBDAbstract
The coronavirus disease 2019 (COVID-19) pandemic is a global problem caused by the SARS CoV-2 virus. Covid-19 vaccination, which is believed to be a solution, started after almost a year of the pandemic. The vaccination program in Indonesia initially used the Sinovac vaccine, a vaccine made from killed or inactivated viruses. This platform has been used in making vaccines for a long time. Vaccination at the UIN Syarif Hidayatullah Jakarta campus uses a vaccine made by PT Bio Farma, COVID-19 Vaccine, with the same raw materials as Sinovac. Cross-sectional research and research subjects were 53 lecturers and teaching staff who had received 2 doses of the COVID-19 Vaccine. Characteristics of age, gender, body mass index, comorbidities and adverse events after immunization (AEFI) were obtained from interviews, questionnaires and physical examination. It was found that there were no significant differences in S-RBD IgG antibody levels in young and elderly adults (p=0.85), male and female groups (p=0.74), groups with comorbidities (p=0.93), history of AEFI (p=0.78). However, there was a significant difference between normal BMI and abnormal BMI (p=0.03). The variable that had a significantly different relationship in this study was the mean level of IgG S-RBD antibodies in the overweight and obese groups with normal weight.
Downloads
References
Al Fajri, A. A. (2022). PERBANDINGAN NILAI CT ANTARA PASIEN SIMPTOMATIK DENGAN ASIMPTOMATIK PADA PENDERITA COVID-19 DI GERAI SWAB SATGAS COVID-19 FAKULTAS KEDOKTERAN UNIVERSITAS HASANUDDIN PERIODE AGUSTUS–SEPTEMBER 2021. Universitas Hasanuddin.
Alkautsar, A. (2021). Hubungan penyakit komorbid dengan tingkat keparahan pasien COVID-19. Jurnal Medika Hutama, 3(01 Oktober), 1488–1494.
Apriyanto, A., & Rasak, A. (2024). THE ROLE OF CLUSTER OF DIFFERENTIATION-8 (CD8) IN THE IMMUNE SYSTEM. SINERGI: Jurnal Riset Ilmiah, 1(2), 70–79.
Cahyati, Y., Somantri, H. I., Kp, S., Kep, M., Ai Cahyati, S. K. M., Kep, M., Kep, N. S., Sugiarti, I., Iman, A. T., & SKM, M. K. M. (2021). Penatalaksanaan terpadu penyakit tidak menular (pedoman bagi kader dan masyarakat). Deepublish.
Fatoni, A. Z., & Rakhmatullah, R. (2021). Acute respiratory distress syndrome (ARDS) pada pneumonia COVID-19. Journal of Anaesthesia and Pain, 2(1), 11–24.
Fitriani, N. I. (2020). Tinjauan pustaka covid-19: virologi, patogenesis, dan manifestasi klinis. Jurnal Medika Malahayati, 4(3), 194–201.
Ghiffari, A. (2023). Dukungan Teknis Mengatasi Pandemi di Masa Depan. Penerbit NEM.
Gunardi, W. D. (2022). Corona Virus Disease 2019 dan Perkembangannya. PT. Scifintech Andrew Wijaya.
Hairunisa, N., & Amalia, H. (2020). Penyakit virus corona baru 2019 (COVID-19). Jurnal Biomedika Dan Kesehatan, 3(2), 90–100.
Hidayah, N. (2020). Dari Jabariyah, ke Qadariyah, hingga islam progresif: respons muslim atas pandemi Covid-19 di Indonesia.
IFANA, V. A. (n.d.). PROBLEMATIKA PELAKSANAAN VAKSINASI DI KABUPATEN DEMAK (STUDI IMPLEMENTASI KEBIJAKAN VAKSINASI COVID-19).
Lamani, K. A. (n.d.). BAB XI: BERSEPEDA DIMASA PANDEMI COVID-19.
Liberty, I. A., Septadina, I. S., Kurniati, A. M., & Ananingsih, E. S. (2023). Monograf Risiko Transmisi COVID-19 pada Ibu Rumah Tangga. Penerbit NEM.
Muderawan, I. W., Giri, M. K. W., Budiawan, M., & Suja, I. W. (2021). KAJIAN TERHADAP KLAIM “ARAK BALI DAN KOPI CAMPUR ARAK SEMBUHKAN COVID-19.†Ganesha Medicina, 1(2), 66–79.
Muslimah, K. I. (n.d.). Faktor Pendorong Kebijakan Lockdown Kerajaan Arab Saudi Sebelum Deklarasi Pandemi Oleh World Health Organization Pada Tahun 2020. Program Studi Ilmu Hubungan Internasional Fakultas Ilmu Sosial Dan Ilmu ….
Noviana, N., Holilah, I., Afrizal, M. I., Khotimah, N. N., Zafa, N. A., & Azizah, N. (2021). Vaksin Aman, Masyarakat Sehat untuk Mendukung Kegiatan Belajar Mengajar Tatap Muka.
NUR AZIZAH, A. F. (2023). EFEKTIVITAS MEDIA VIDEO TERHADAP PENINGKATAN PENGETAHUAN DAN SIKAP LANSIA TENTANG VAKSINASI COVID-19 DI RW 10 KELURAHAN SUKAMANAH KOTA TASIKMALAYA. Universitas Siliwangi.
Pangandaheng, T., Suryani, L., Syamsiah, N., Kombong, R., Kusumawati, A. S., Masithoh, R. F., Eltrikanawati, T., Nurjanah, U., Eldawati, E., & Sasmito, P. (2023). Asuhan Keperawatan Medikal Bedah: Sistem Respirasi dan Kardiovaskuler. PT. Sonpedia Publishing Indonesia.
Prakoeswa, F. R. (2020). Peranan sel limfosit dalam imunulogi: Artikel review. Jurnal Sains Dan Kesehatan, 2(4), 525–537.
Rosyanti, L., & Hadi, I. (2020). Respon imunitas dan badai sitokin severe acute respiratory syndrome corona virus 2: Literatur review. Jurnal Kesehatan Madani Medika (JKMM), 11(2), 176–201.
Simak, V. F. (2020). TINGKAT PENGETAHUAN DAN STRATEGI KOPING MASYARAKAT INDONESIA MENGHADAPI PANDEMI COVID-19. Jurnal Ilmiah Keperawatan IMELDA, 6(2), 158–163.
Solikah, N., & Ismiatun, I. (2023). Alasan Amerika Serikat Keluar Dari WHO Pada Saat Pandemi Covid 2020. Kajian Hubungan Internasional, 2(1), 458–473.
SURYANI, A., Heriyanto, H., Elly, N., & Budaya, R. (2020). Asuhan Keperawatan Manajemen Nutrisi pada Pasien TB Paru di Ruang Kemuning RSUD Dr. M. Yunus Bengkulu Tahun 2020.
Susilo, A., Rumende, C. M., Pitoyo, C. W., Santoso, W. D., Yulianti, M., Herikurniawan, H., Sinto, R., Singh, G., Nainggolan, L., & Nelwan, E. J. (2020). Coronavirus disease 2019: review of current literatures. Jurnal Penyakit Dalam Indonesia, 7(1), 8.
TAMITA, K. (2023). Hubungan Tingkat Pengetahuan Dengan Kepatuhan Vaksinasi Covid-19 Pada Lansia Di Kelurahan Babura Kecamatan Medan Sunggal. Fakultas Kedokteran, Universitas Islam Sumatera Utara.
Yanuhar, U., & Caesar, N. R. (2021). Teknologi Rekombinan Vaksin untuk Ikan. Universitas Brawijaya Press.
Zendrato, W. (2020). Gerakan mencegah daripada mengobati terhadap pandemi covid-19. Jurnal Education and Development, 8(2), 242.
